Linklaters and Clifford Chance have won mandates advising on a $6.8bn (£4.6bn) financing for Belgian company Solvay's takeover of US chemical group Cytec Industries.

Solvay completed the acquisition earlier this month but only confirmed last week that it had finalised the financing of the takeover.

Linklaters advised Solvay on the deal with a team led by Brussels corporate partner Arnaud Coibion and Paris capital markets partner Luis Roth.

CC advised banks including Credit Suisse, Morgan Stanley, BNP Paribas Fortis, Morgan Stanley and HSBC on the equity and debt capital markets offerings.

Its team was led from Paris by US securities partner Alex Bafi (pictured), and debt capital markets partner Cedric Burford alongside Brussels equity capital markets partner Philippe Hamer and London equity capital markets partner Simon Thomas.

On the merger, Sullivan & Cromwell represented Cytec with a team including New York M&A partner Melissa Sawyer. Davis Polk & Wardwell advised on M&A for Solvay. Its team was led by Paris corporate partner Jacques Naquet-Radiguet alongside New York corporate partner William Aaronson and London corporate partner Nick Benham. Linklaters advised on the Belgium elements with a team led by Brussels corporate partner Arnaud Coibion.

There has been a spate of consolidation in the chemicals sector this year. In July, UK listed petrochemical group Ineos signed a 50:50 joint venture with Solvay.

Slaughter and May advised Ineos alongside firms in local jurisdictions such as Cravath Swaine & Moore, which advised on New York law.

More recently, Skadden Arps Slate Meagher & Flom and Weil Gotshal & Manges won mandates on a proposed merger between Dow Chemical and DuPont in a deal valuing them at $130bn (£86bn).

Earlier this year, Shearman & Sterling and Cravath Swaine & Moore won lead spots advising as Dow Chemical spun off its chlorine business for $5bn (£3.4bn) to smaller rival Olin Corporation.